New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells

Abstract Metastasis is the primary cause of death in lung cancer patients. However, until now, effective drugs and intervention strategies for treating lung cancer metastasis have been lacking. This hypothesis focuses on circulating tumour cells (CTCs) to develop a new antimetastatic therapeutic str...

Full description

Bibliographic Details
Main Authors: Zujun Que, Jianhui Tian
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-022-02782-w
_version_ 1797984045660897280
author Zujun Que
Jianhui Tian
author_facet Zujun Que
Jianhui Tian
author_sort Zujun Que
collection DOAJ
description Abstract Metastasis is the primary cause of death in lung cancer patients. However, until now, effective drugs and intervention strategies for treating lung cancer metastasis have been lacking. This hypothesis focuses on circulating tumour cells (CTCs) to develop a new antimetastatic therapeutic strategy for lung cancer. Here, we outline the role of CTCs in tumour metastasis and their functional effects during the treatment of lung cancer patients. Additionally, we hypothesized the possibility of CTCs as a novel biomarker and therapeutic target in preventing and treating metastasis in patients with early-stage lung cancer. We hope that the realization of this hypothesis will improve the overall survival of lung cancer.
first_indexed 2024-04-11T06:56:31Z
format Article
id doaj.art-3cf90a943dc04013a635a3c9dd6bdc1e
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-04-11T06:56:31Z
publishDate 2022-11-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-3cf90a943dc04013a635a3c9dd6bdc1e2022-12-22T04:39:01ZengBMCCancer Cell International1475-28672022-11-012211410.1186/s12935-022-02782-wNew strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cellsZujun Que0Jianhui Tian1Institute of Oncology, Shanghai Municipal Hospital of TCM, Shanghai University of Traditional Chinese Medicine (TCM)Institute of Oncology, Shanghai Municipal Hospital of TCM, Shanghai University of Traditional Chinese Medicine (TCM)Abstract Metastasis is the primary cause of death in lung cancer patients. However, until now, effective drugs and intervention strategies for treating lung cancer metastasis have been lacking. This hypothesis focuses on circulating tumour cells (CTCs) to develop a new antimetastatic therapeutic strategy for lung cancer. Here, we outline the role of CTCs in tumour metastasis and their functional effects during the treatment of lung cancer patients. Additionally, we hypothesized the possibility of CTCs as a novel biomarker and therapeutic target in preventing and treating metastasis in patients with early-stage lung cancer. We hope that the realization of this hypothesis will improve the overall survival of lung cancer.https://doi.org/10.1186/s12935-022-02782-wLung cancerCirculating tumour cellsAntimetastaticTherapeutic strategyBiomarker
spellingShingle Zujun Que
Jianhui Tian
New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
Cancer Cell International
Lung cancer
Circulating tumour cells
Antimetastatic
Therapeutic strategy
Biomarker
title New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
title_full New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
title_fullStr New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
title_full_unstemmed New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
title_short New strategy for antimetastatic treatment of lung cancer: a hypothesis based on circulating tumour cells
title_sort new strategy for antimetastatic treatment of lung cancer a hypothesis based on circulating tumour cells
topic Lung cancer
Circulating tumour cells
Antimetastatic
Therapeutic strategy
Biomarker
url https://doi.org/10.1186/s12935-022-02782-w
work_keys_str_mv AT zujunque newstrategyforantimetastatictreatmentoflungcancerahypothesisbasedoncirculatingtumourcells
AT jianhuitian newstrategyforantimetastatictreatmentoflungcancerahypothesisbasedoncirculatingtumourcells